We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will Pricing Sustain Procter & Gamble as Volume Growth Stays Elusive?
Read MoreHide Full Article
Key Takeaways
PG expects a $1.4 billion after-tax earnings headwind in fiscal 2027, equal to about 8% of 2026 core EPS.
Procter & Gamble sees fiscal Q1 EPS falling 5% or more as cost pressures peak in the first half.
PG delivered $2.8 billion in pretax productivity gains in fiscal 2026 to help offset rising cost pressures.
The Procter & Gamble Company (PG - Free Report) enters fiscal 2027 with a greater focus on balancing pricing with volume growth as it navigates a challenging consumer environment and elevated costs. In fiscal 2026, organic sales increased 1%, with pricing contributing one point, while volume was up modestly for the fiscal year. However, momentum remained limited in the fourth quarter, when volume rounded down to flat and pricing and mix were neutral.
Pricing can provide a near-term lift to sales, particularly when backed by strong brands, product innovation and perceived value. However, sustained volume growth remains important for PG, as higher unit sales can provide a broader and more durable foundation for revenue growth. At the same time, continued price increases may put pressure on consumer affordability, potentially prompting shoppers to trade down, opt for private-label products or reduce purchase frequency.
Nevertheless, PG does not intend to rely solely on pricing to support growth. Management expects promotions to move toward pre-pandemic levels while continuing to drive price/mix. The company has been emphasizing innovation designed to support pricing while delivering stronger value to consumers. Management expects this approach to result in a more balanced contribution from volume, price and mix in fiscal 2027.
That said, PG’s diverse portfolio of leading brands, continued innovation, productivity initiatives and premium offerings should support growth. The company is also focused on enhancing consumer value through effective price-pack architecture while strengthening brand equity. Going forward, PG’s fiscal 2027 growth strategy is likely to emphasize innovation, volume recovery, disciplined pricing and productivity gains, reducing its reliance on pricing as the primary growth driver.
PG’s Competition
Colgate-Palmolive Company (CL - Free Report) is enhancing its operations to become more connected, efficient and resilient by leveraging digital technologies, data analytics, automation and stronger supplier collaboration. CL’s productivity initiatives are increasingly playing a critical role in supporting margins as it navigates persistent cost inflation and uneven category demand. With a diversified portfolio of everyday consumer essentials spanning multiple price points and a strong presence in faster-growing emerging markets, Colgate is well-positioned to drive sustainable growth and strengthen its competitive position.
The Clorox Company (CLX - Free Report) is implementing a streamlined operating model designed to simplify processes, lower costs and create a faster, more focused organization. CLX is optimizing its portfolio, increasing investments in innovation and brand building, and expanding its presence in the health and hygiene categories. These initiatives, supported by greater sourcing flexibility and adaptable business models, are helping Clorox manage cost inflation while advancing its strategic priorities and strengthening operational efficiency.
PG’s Price Performance, Valuation and Estimates
Procter & Gamble’s shares have gained 3% in the past six months compared with the industry’s 2% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, PG is trading at a forward price-to-earnings ratio of 20.67X compared with the industry’s average of 18.25X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for PG’s fiscal 2027 and fiscal 2028 earnings per share (EPS) indicates year-over-year growth of 1.5% and 6.2%, respectively. The company’s EPS estimate for fiscal 2027 has moved south while that of fiscal 2028 has been stable in the past 30 days.
Image Source: Zacks Investment Research
Procter & Gamble currently carries a Zacks Rank #3 (Hold).
View the Zacks #1 Rank List
Image: Bigstock
Will Pricing Sustain Procter & Gamble as Volume Growth Stays Elusive?
Key Takeaways
The Procter & Gamble Company (PG - Free Report) enters fiscal 2027 with a greater focus on balancing pricing with volume growth as it navigates a challenging consumer environment and elevated costs. In fiscal 2026, organic sales increased 1%, with pricing contributing one point, while volume was up modestly for the fiscal year. However, momentum remained limited in the fourth quarter, when volume rounded down to flat and pricing and mix were neutral.
Pricing can provide a near-term lift to sales, particularly when backed by strong brands, product innovation and perceived value. However, sustained volume growth remains important for PG, as higher unit sales can provide a broader and more durable foundation for revenue growth. At the same time, continued price increases may put pressure on consumer affordability, potentially prompting shoppers to trade down, opt for private-label products or reduce purchase frequency.
Nevertheless, PG does not intend to rely solely on pricing to support growth. Management expects promotions to move toward pre-pandemic levels while continuing to drive price/mix. The company has been emphasizing innovation designed to support pricing while delivering stronger value to consumers. Management expects this approach to result in a more balanced contribution from volume, price and mix in fiscal 2027.
That said, PG’s diverse portfolio of leading brands, continued innovation, productivity initiatives and premium offerings should support growth. The company is also focused on enhancing consumer value through effective price-pack architecture while strengthening brand equity. Going forward, PG’s fiscal 2027 growth strategy is likely to emphasize innovation, volume recovery, disciplined pricing and productivity gains, reducing its reliance on pricing as the primary growth driver.
PG’s Competition
Colgate-Palmolive Company (CL - Free Report) is enhancing its operations to become more connected, efficient and resilient by leveraging digital technologies, data analytics, automation and stronger supplier collaboration. CL’s productivity initiatives are increasingly playing a critical role in supporting margins as it navigates persistent cost inflation and uneven category demand. With a diversified portfolio of everyday consumer essentials spanning multiple price points and a strong presence in faster-growing emerging markets, Colgate is well-positioned to drive sustainable growth and strengthen its competitive position.
The Clorox Company (CLX - Free Report) is implementing a streamlined operating model designed to simplify processes, lower costs and create a faster, more focused organization. CLX is optimizing its portfolio, increasing investments in innovation and brand building, and expanding its presence in the health and hygiene categories. These initiatives, supported by greater sourcing flexibility and adaptable business models, are helping Clorox manage cost inflation while advancing its strategic priorities and strengthening operational efficiency.
PG’s Price Performance, Valuation and Estimates
Procter & Gamble’s shares have gained 3% in the past six months compared with the industry’s 2% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, PG is trading at a forward price-to-earnings ratio of 20.67X compared with the industry’s average of 18.25X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for PG’s fiscal 2027 and fiscal 2028 earnings per share (EPS) indicates year-over-year growth of 1.5% and 6.2%, respectively. The company’s EPS estimate for fiscal 2027 has moved south while that of fiscal 2028 has been stable in the past 30 days.
Image Source: Zacks Investment Research
Procter & Gamble currently carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.